This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC Post-Op CRT - Final Results of JCOG1008

135 views
September 20, 2024
0 Comments
Login to view comments. Click here to Login